Trinity Biotech (TRIB) Net Income Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) Net Income Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 280.49% |
| 10 | Trinity Biotech | 107.10 Mn | 101.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -778.59% |
| Sep 30, 2024 | -450.16% |
| Jun 30, 2024 | -148.36% |
| Mar 31, 2024 | -39.67% |
| Dec 31, 2023 | 28.43% |
| Sep 30, 2023 | -41.18% |
| Jun 30, 2023 | 91.63% |
| Mar 31, 2023 | -45.62% |
| Dec 31, 2022 | 35.41% |
| Sep 30, 2022 | -209.07% |
| Jun 30, 2022 | -58.48% |
| Mar 31, 2022 | 34.93% |
| Dec 31, 2021 | 89.98% |
| Sep 30, 2021 | -27.41% |
| Jun 30, 2021 | -17.01% |
| Mar 31, 2021 | 64.67% |
| Dec 31, 2020 | 29.40% |
| Sep 30, 2020 | 136.05% |
| Jun 30, 2020 | 19.27% |
| Mar 31, 2020 | 95.32% |